RE: Observation24 Apr 2018 15:10
TomE
Be careful with pharmaceuticals on AIM, it is a complete gamble. There are lost of the cancer drugs development companies all trying to do a similar thing. I invested in Scancell (SCLP) some years ago, I was lucky i made a bit of moeny and got out. My friend wasn't so lucky he tied alot of money (�50k) up at an average of about 45p a share, the SCLP share price is currentley 12p. It was recently 19p but then the company announced another Subscription of �7.5 million of shares at 12p. That sent the price south to 12p.